MEViiK

Meviik Health Research · independent consultancy

A clinician-led consultancy for health research, evidence and real-world data.

Evidence delivered.
Skills that stay.

We work with pharma, health-tech, universities, the NHS and global-health organisations — from study design to analysis, evidence synthesis and public involvement — delivering research you can act on, and leaving your team the skills to build on it.

Capability index

Fig. 1 — Capability index, drawn as a forest plot. A device, not a dataset.

Two ways to work

Commission the work, or put us on the bid.

01 — Commissioned

You need it delivered

Advisory and day-rate input, fixed-scope projects, trial support, retained capacity, or a training programme built for a specific cohort.

02 — In partnership

You need it to stand up

Named collaborator or co-investigator on grant applications, consortium bids and joint studies — with the methods written to survive review.

Who we help

Built for the people who commission evidence — and those who produce it.

Pharma, biotech & health-tech

Real-world evidence, safety and outcomes studies, and evidence synthesis to support development, regulatory and market-access decisions — designed to stand up to scrutiny.

Universities & research consortia

A named co-investigator and methods partner for grant applications and joint studies — study design, statistical analysis plans, and the epidemiological rigour reviewers look for.

NHS & public-health bodies

Analysis of routine and linked healthcare data to understand outcomes, pathways and inequalities, translated into evidence that informs service and policy decisions.

Charities & patient organisations

Meaningful patient and public involvement, evidence reviews, and plain-language resources that put the people affected at the centre of the research.

Global-health organisations & NGOs

Epidemiology, evidence synthesis and study design for population-health questions across settings — including where data and resources are constrained.

Teams who want to build capability

Training and mentoring in study design, trials, epidemiology, qualitative methods and evidence synthesis — customised to the cohort in the room, not off the shelf.

Where we go deep

The questions others find hard to answer.

We work across conditions, populations and settings. Three areas run deepest — chosen because the evidence is thin, the populations are routinely excluded from trials, and the methods are genuinely difficult. Strengths, not limits.

01

Women's & maternal health

A field with decades of under-investment and a widening gap between what is funded and what is known.

02

Multiple long-term conditions

Multimorbidity breaks single-disease methods. Clustering, life-course analysis and core outcome sets.

03

Medication safety

Pharmacoepidemiology and signal detection where trials cannot ethically go — including in pregnancy.

The network

A hub, not a fixed team.

Good research needs more expertise than any one person holds. Collaborators are brought in to fit the question, rather than forcing the question to fit whoever is available.

  • Clinicians across specialties
  • Statisticians
  • Epidemiologists
  • Pharmacoepidemiologists
  • Health economists
  • Data engineers
  • Data scientists
  • Prediction modellers
  • Qualitative researchers
  • Social scientists
  • PPIE leads
  • Patient partners
  • Information specialists
  • Trial managers
  • Research nurses
  • Medical writers
  • Regulatory specialists
  • Academic co-investigators

The network is open. If you work in any of these areas — or somewhere not listed — and want to collaborate on a project, a grant application or a joint study, get in touch.

Dr Megha Singh, founder of Meviik

The expertise behind Meviik

Dr Megha Singh, Founder

  • MBBS — clinician
  • MPH — public health
  • PhD — applied health research

Population-scale studies on large linked healthcare datasets. Qualitative and mixed-methods research. Systematic and umbrella reviews with meta-analysis. Core outcome set development. And a multinational, MRC-funded research programme across the four UK nations, coordinating academic, NHS, industry and patient partners.

The combination is unusual: clinical understanding of what the data represents, the statistical skill to work with it at scale, the methodological range to know when numbers are the wrong tool, and the delivery experience to land a programme on time.

Selected publications

The evidence behind the consultancy.

A selection of peer-reviewed work by the founder, spanning real-world cohort studies, evidence synthesis and large-scale epidemiology in women's health, autoimmune disease, multimorbidity and long COVID.

Much of this work was carried out within MuM-PreDiCT, a multinational MRC-funded research programme on multiple long-term conditions in pregnancy spanning the four UK nations.

Start a conversation

Every engagement starts with a scoping call.

No cost, no obligation — its only job is to work out whether we are the right people for your question, and what answering it would actually involve. If we are not, we will say so.

info@meviik.com LinkedIn